Pain News: “Reckitt Benckiser sued by 35 US states for ‘profiteering’ from opioid treatment”


.

.

.

Headlines today from the Guardian:

.

“Reckitt Benckiser sued by 35 US states for ‘profiteering’ from opioid treatment”

.

.

There really is no financial advantage for pharmaceutical companies to create medication that helps pain because opioids are for life, and are so valuable some of them can charge each patient $20,000 a month. For life. Explains why every year 2 or 3 new opioids come on the market, year after year after year, more new opioids.

.

Opioid profiteering.

.

.

.

.

.

The material on this site is for informational purposes only, and is not a substitute for medical advice,

diagnosis or treatment provided by a qualified health care provider.

~

Please understand that it is not legal for me to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

~

~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

.

.

The advertising below is not recommended by me.

.

.

.

.

Abuse & Misuse Risk Assessment Tools from FDA – for Opioids, Ketamine, Adderall, Xanax, Ativan, Valium, Any Drugs of Abuse


.

.

.

Risk Assessment Tools Examples from FDA.gov

page 11  (pdf)

.

.

We must always remember, all of us, families, friends and physicians alike, the possibility of opioid use disorder (OUD) in anyone on chronic opioid therapy (COT) and those who are prescribed any drugs of abuse such as Ketamine, Adderall and benzodiazepines such as Valium, Ativan, Xanax. None of us should be taking medications that interfere with our ability to think and function. None of us should be taking more than we need. Many of us do not realize that less is more.

.

Details of many tools for risk assessment are reviewed previously here.

.

Keep this in mind:

.

  • “Assessing risk of abuse and OUD in patients receiving COT is a dynamic, ongoing process.

    .

  •  Diagnosing misuse, abuse and OUD in patients with pain is complex

    .

  • Current screening tools do not diagnose abuse or OUD but only misuse and not intent”

     

.

.

Tools

# of Items

 Administered

Patients considered for long-term opioid therapy:

ORT Opioid Risk Tool

5

By patient

SOAPP® Screener & Opioid Assessment for Patients w/ Pain

24, 14, & 5

By patient

DIRE Diagnosis, Intractability, Risk, & Efficacy Score

7

By clinician

Characterize misuse once opioid treatments begins:

PMQ Pain Medication Questionnaire

26

By patient

COMM Current Opioid Misuse Measure

17

By patient

PDUQ Prescription Drug Use Questionnaire

40

By clinician

Not specific to pain populations:

CAGE-AID Cut Down, Annoyed, Guilty, Eye-Opener Tool, Adjusted to Include Drugs

4

By clinician

RAFFT Relax, Alone, Friends, Family, Trouble

5

By patient

DAST Drug Abuse Screening Test

28

By patient

SBIRT Screening, Brief Intervention, & Referral to Treatment

Varies

By clinician

 

Doctors Without Borders Refuses Million Free Vaccines – Pfizer Charges Too Much


.

.

.

Doctors Without Borders Refuses One Million Free Vaccines – Pfizer Charges Too Much

.

.

Pneumonia is the #1 cause of death in children. Pfizer’s revenue from this vaccine to prevent pneumonia was $6.245 billion last year – the same as United Airlines entire revenue.

.

It’s the principle. Millions may die without the vaccine. Pharma has no shame.

.

.

 

.

.


The material on this site is for informational purposes only, and is not a substitute for medical advice,

diagnosis or treatment provided by a qualified health care provider.

~

Please understand that it is not legal for me to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

~

~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

.

.

The advertising below is not recommended by me.

.

.

.

.

.

.

.

.

 

 

.

 

 

 

 

Unless referred by local physician, Dr. Sajben is no longer accepting new patients


.

.

.

Unless referred by a local physician,

Dr. Sajben is no longer accepting new patients.

.

 

.

I continue to train physicians in use of medications including glial modulators that are often highly effective for intractable pain, major depression, bipolar depression or PTSD that have failed all commonly used therapies.

.

See here for information on physician training.

.

The physician needs to call me and schedule 3 hours after they have read the link above. Do not ask me to call your MD. The science is there, just waiting to be applied, referenced on 7 years of these pages since April 2009.

.

Physicians all over the world have asked me to train them as they see intractable conditions, not uncommonly their own loved ones. The science is not new, but the clinical paradigm must change. This work with glial modulators needs to be clinically studied. Who knows how many cases will respond, even go into remission despite 20 years and 3 suicide attempts for CRPS pain. Now pain free for years.

.

Ketamine alone is not the answer. I have posted on that.

 .

Patients themselves find on the internet that antidepressants only help 30%, some have intolerable side effects or no effect from commonly used medications, procedures and surgeries. Did opioids cause your pain? Did they ever help?

 .

Patients know how expensive it can be to travel here and remain a few days while we begin medication. Local doctors who care about helping may be interested in seeing results.

.

It’s up to caring healers and smart readers who know how hard its been. That condition could be put into remission. It may not be intractable.

.

.

.

.

.


The material on this site is for informational purposes only, and is not a substitute for medical advice,

diagnosis or treatment provided by a qualified health care provider.

~

Please understand that it is not legal for me to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

~

~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

.

.

The advertising below is not recommended by me.

.

.

.

.

.

.

.

.

Vulvodynia Topical Treatment – Monotherapy Obsolete


.

.

.

New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells

.

Authors Keppel Hesselink JM, Kopsky DJ, Sajben N
.

Journal of Pain Research 2016, 9:757-762

 

.

.

Abstract: Topical treatments of localized neuropathic pain syndromes in general are mostly neglected, mainly due to the fact that most pain physicians expect that a topical formulation needs to result in a transdermal delivery of the active compounds. On the basis of the practical experience, this study brings forth a new, somewhat neglected element of the vulvodynia pathogenesis: the cross talk between the nerve endings of nociceptors, the adjacent immunocompetent cells, and vaginal epithelial cells. Insight into this cross talk during a pathogenic condition supports the treatment of vulvodynia with topical (compounded) creams. Vulvodynia was successfully treated with an analgesic cream consisting of baclofen 5% together with the autacoid palmitoylethanolamide 1% [Pea, PeaPure], an endogenous anti-inflammatory compound. In this review, data is presented to substantiate the rationale behind developing and prescribing topical products for localized pain states such as vulvodynia. Most chronic inflammatory disorders are based on a network pathogenesis, and monotherapeutic inroads into the treatment of such disorders are obsolete.

.

.

.

[Vitalitus, the American manufacturer of PEA, expects to have their first batch of cream for sale in 2 weeks. It’s a 2% PEA cream.]

.

.

.

.

.

.

 


The material on this site is for informational purposes only, and is not a substitute for medical advice,

diagnosis or treatment provided by a qualified health care provider.

~

Please understand that it is not legal for me to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

~

~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

.

.

The advertising below is not recommended by me.

.

.

.

.

.

.

.

.

 

 

 

Opioid Production in US Cut 25% by DEA in 2017


.

.

.

The DEA regulates how much opioid is allowed to be made each year. Production will be cut by 25% in 2017. Some will be cut by more than 25%, for example hydrocodone will be cut 34%.

.

The reasons given are that demand is falling and the opioid epidemic is not. Congress of course could think about funding addiction treatment and offering clean injection sites for addicts such as Vancouver’s.

.

The order will be published tomorrow in the Federal Register.

.

.

 

In June 2016, Senator Richard Durbin interrogated Chuck Rosenberg, acting administrator of the Drug Enforcement Administration (DEA), during a Senate Judiciary Hearing.

.

Durbin has introduced legislation to fight opioid abuse. One section of the bill would require DEA to consider opioid addiction when setting production quotas. If annual quotas increase, DEA would be required to justify that in writing, explaining why the bump outweighs the risk of having more addictive drugs available.

.
Opioid death stats demonstrate the ravages of the epidemic.
.
About 47,000 people died from overdoses in 2014, Rosenberg said. That’s 129 every day. About 61 percent were due to prescription opioid and heroin.

.

 

.

.

.

.


The material on this site is for informational purposes only, and is not a substitute for medical advice,

diagnosis or treatment provided by a qualified health care provider.

~

Please understand that it is not legal for me to give medical advice without a consultation.

If you wish an appointment, please telephone my office.

~

~

For My Home Page, click here:  Welcome to my Weblog on Pain Management!

.

.

.

The advertising below is not recommended by me.

.

.

.

.

.

.

.

.

.

 

%d bloggers like this: